1 / 3

Global Rheumatoid Arthritis Market Research Report 2021-2026

The Global Rheumatoid Arthritis Market was valued at USD 24.46 Billion in the year 2020. Globally, the market for rheumatoid arthritis is increasing rapidly and the major factor that drives the growth of rheumatoid arthritis is the increasing ageing population. Furthermore, some evidence suggests that people who smoke are at an increased risk of developing rheumatoid arthritis.

priyapraksh98
Télécharger la présentation

Global Rheumatoid Arthritis Market Research Report 2021-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Rheumatoid Arthritis Market - Analysis By Drug Type, Treatment, Diagnosis, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026) Bharat Book Bureau Provides the Trending Industry Research Report on “Global Rheumatoid Arthritis Market (2021 Edition) - Analysis By Drug Type (NSAIDs, DMARDs, Corticosteroids, Others), Treatment, Diagnosis, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)”under Life Sciences Market Research Report Category. The report offers a collection of superior Industry research, Industry analysis, competitive intelligence and Industry reports. The Global Rheumatoid Arthritis Market was valued at USD 24.46 Billion in the year 2020. Globally, the market for rheumatoid arthritis is increasing rapidly and the major factor that drives the growth of rheumatoid arthritis is the increasing ageing population. Furthermore, some evidence suggests that people who smoke are at an increased risk of developing rheumatoid arthritis. DMARDs segment is expected to hold a significant share in the Rheumatoid Arthritis Market on the back of the increasing prevalence of rheumatoid arthritis incidences across the globe, the launch of the therapeutic agents, and the favourable reimbursement policies for the high-cost treatment products. These are the major factors propelling the growth of the market. Americas region dominated the global Rheumatoid Arthritis market and led the industry in 2020 owing to the presence of a large patient base and availability of well-developed infrastructure, rising awareness regarding disease treatment, growing geriatric population, and high adoption of biopharmaceuticals for treatment. There is also an increase in funds provided to academic research institutions and individual researchers that is expected to boost the market growth. Moreover,

  2. various initiatives by international bodies, such as WHO and NIH for the prevention and treatment of chronic disorders, such as cardiovascular diseases, Rheumatoid Arthritis and cancer are anticipated to facilitate the growth of the market. Scope of the Report • The report presents the analysis of the Rheumatoid Arthritis market for the historical period of 2016-2020 and the forecast period of 2021-2026. • The report analyses the Rheumatoid Arthritis Market by Value (USD Million). • The report analyses the Rheumatoid Arthritis Market By Drug Type – NSAID(non- steroidal anti-inflammatory drugs), DMARDs (Disease-modifying anti-rheumatic drug), Corticosteroids, Others • The report analyses the Rheumatoid Arthritis Market by Treatment – Tendon Repair, Joint Fusion, Joint Replacement, Others. • The report analyses the Rheumatoid Arthritis Market By Diagnosis – CRP (Creative Protein Test), ESR (Erythrocyte Sedimentation Rate), Others. • The Global Rheumatoid Arthritis Market has been analysed by countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). • Also, the attractiveness of the market has been presented by region, by Drug Type, by Treatment, By Diagnosis. • Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report. • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck KGaA, Sanofi, Eli Lilly Company, Amgen Inc., Bristol-Mayor Squibb, F. Hoffman-La Roche Ltd., Johnson & Johnson, Cipla, Pfizer, Galapagos NV, Gilead Sciences. Key Target Audience • Pharmaceutical Companies • Consulting and Advisory Firms • Government and Policy Makers • Regulatory Authorities Browse our full report with Table of Content : https://www.bharatbook.com/report/1063610/global-rheumatoid-arthritis- market-edition-analysis-by-drug-type-nsaids-dmards-corticosteroids-others- treatment-diagnosis-by-region-by-country-market-insights-and-forecast-with- impact-of-covid About Bharat Book Bureau: Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a

  3. comprehensive coverage of major industries with a further segmentation of 100+ subsectors. Contact us at: Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Website: www.bharatbook.com

More Related